Quagen Pharma India Private Limited, a active foreign private limited company, was established on 10 March 2015 in Visakhapatnam, Andhra Pradesh, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U74900AP2015FTC096297. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹45.00 Cr and a paid-up capital of ₹32.44 Cr.
It upholds a active non-compliant status. Employing 4 professional, Its leadership includes Narsinh Keshar Desai (Director), Ashish Arunkumar Shah (Managing Director). Past directors included Srikanth Dandamudi, Ashish Arunkumar Shah, Surya Regulagadda Narayana. Its latest AGM occurred on 29 September 2018, with the balance sheet filed on 31 March 2018. It is based at R & D Building, Ground Floor, Ramky Pharmacity Commercial Hub Junction, Pharma City, Pa, Rawada, Visakhapatnam, Andhra Pradesh, 530019.
U74900AP2015FTC096297
096297
10 March 2015
₹45.00 Cr
₹32.44 Cr
Roc Vijayawada
Unlisted
Active
Explore comprehensive insights into Quagen Pharma India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Narsinh Keshar Desai | Director | 21 Apr 2015 | Current |
| Ashish Arunkumar Shah | Managing Director | 26 Mar 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 06 Sep 2024 | Past |
| Pramod Abcsdd | Director | 30 Apr 2015 | Past |
| Pramod Abcsdd | Director | 21 Apr 2015 | Past |
| Pramod Abcsdd | Director | 26 Mar 2015 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Quagen Pharma India Private Limited, for the financial year ended 2018, experienced modest growth in revenue, with a 5.86% increase. The company also saw a substantial improvement in profitability, with a 86.47% increase in profit. The company's net worth dipped by a decrease of 0.08%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2018, Quagen Pharma India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Quagen Pharma India has a workforce of 4 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Quagen Pharma India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Quagen Pharma India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Rimpy Choudhury was appointed as a Company Secretary was appointed as a Company Secretary on 15 Dec 2019 & has been associated with this company since 5 years 11 months . was recorded as a recent event.
The activity Quagen Pharma India Private Limited last Annual general meeting of members was held on 29 Sep 2018 as per latest MCA records. was completed.
The activity Quagen Pharma India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Vijayawada. was completed.
Narsinh Keshar Desai was appointed as a Director was appointed as a Director on 21 Apr 2015 & has been associated with this company since 10 years 7 months . was recorded as a recent event.
Ashish Arunkumar Shah was appointed as a Managing Director was appointed as a Managing Director on 26 Mar 2015 & has been associated with this company since 10 years 8 months . was recorded as a recent event.
Quagen Pharma India Private Limited was registered on 10 Mar 2015 with Roc Vijayawada & aged 10 years 8 months as per MCA records. was recorded as a recent event.
The CIN of Quagen Pharma India Private Limited is U74900AP2015FTC096297.
Quagen Pharma India Private Limited is headquartered at R & D Building, Ground Floor, Ramky Pharmacity Commercial Hub Junction, Pharma City, Pa, Rawada, Visakhapatnam, Andhra Pradesh, 530019.
Quagen Pharma India Private Limited was incorporated on 10 March 2015.
The current directors of Quagen Pharma India Private Limited are
The primary industry of Quagen Pharma India Private Limited is Pharma.
Quagen Pharma India Private Limited is unlisted.
The authorized capital of Quagen Pharma India Private Limited is ₹45.00 Cr, and the paid-up capital is ₹32.44 Cr.
The compliance status of Quagen Pharma India Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX